Following best practices for SN EN ISO 11607-2:2020 compliance is crucial for ensuring the safety and effectiveness of terminally sterilized medical devices. Adhering to these practices not only streamlines the validation process but also enhances audit readiness.

Best practices at a glance

This checklist outlines best practices that align with SN EN ISO 11607-2:2020 clauses, focusing on critical areas such as validation of packaging processes and compliance with sterile barrier system requirements. By implementing these practices, organizations can mitigate risks and ensure compliance with ISO 11607-2:2019 standards.

The practices

1. Conduct thorough validation of forming processes
   Validate all forming processes to ensure they meet defined requirements and produce packaging that can withstand the sterilization process. This is crucial to avoid packaging failures that could compromise device sterility and integrity, as stated in Clause 5.3 of SN EN ISO 11607-2:2020.

2. Implement rigorous sealing process validation
   Ensure that sealing processes are validated to guarantee that seals maintain sterility and prevent contamination. Non-compliance can lead to product recalls or safety hazards, which are addressed in Clause 5.4 of the standard. Validation helps satisfy auditor expectations and enhances product reliability.

3. Establish comprehensive assembly process validation
   Validate assembly processes to ensure that all components fit together correctly and that the final product meets all packaging requirements. This practice is essential for maintaining device integrity and is referenced in Clause 5.5 of SN EN ISO 11607-2:2020.

4. Utilize preformed sterile barrier systems effectively
   Use preformed sterile barrier systems that comply with ISO standards. These systems are critical for protecting medical devices during storage and transportation, as outlined in Clause 6.1. Their proper use minimizes risks associated with contamination.

5. Choose appropriate sterile barrier systems
   Select sterile barrier systems that are validated for the specific type of sterilization process used. The choice impacts the effectiveness of sterilization and is crucial as per Clause 6.2. Proper selection reduces risks of device compromise.

6. Adhere to packaging system specifications
   Ensure that all packaging systems are designed and validated according to their intended use and sterilization methods, in line with Clause 7 of the standard. This practice helps prevent packaging-related failures that could lead to non-compliance.

7. Integrate aseptic manufacturing requirements
   Implement aseptic manufacturing requirements as part of the packaging process to maintain sterility throughout production. This is essential for compliance with Clause 8, which emphasizes the importance of maintaining a sterile environment to protect device integrity.

8. Address drug/device combination requirements
   For combination products, validate packaging processes that consider both drug and device aspects to ensure regulatory compliance. As stated in Clause 9, understanding these requirements is critical for successful product development and marketability.

Audit preparation checklist

• Validate forming processes according to Clause 5.3.
• Ensure sealing processes are rigorously validated per Clause 5.4.
• Validate assembly processes aligning with Clause 5.5.
• Utilize validated preformed sterile barrier systems as per Clause 6.1.
• Choose appropriate sterile barrier systems according to Clause 6.2.
• Adhere to packaging system specifications set out in Clause 7.
• Integrate aseptic manufacturing requirements from Clause 8.
• Address drug/device combination requirements in line with Clause 9.

Next steps

To delve deeper into ISO 11607-2:2019 compliance requirements, consider pursuing training programs, implementing detailed guides, and obtaining the latest version of the standard for comprehensive understanding and application.